4949

    500288

    MOREPENLAB

    No Data Available

    Looking to invest in Morepen Laboratories Ltd? Open a Demat account in minutes.

    Morepen Laboratories Ltd Share Price Today

    Morepen Laboratories Ltd is currently trading at ₹98.37, up by ₹3.94 from the previous close. The stock touched an intraday high of ₹99.15 and a low of ₹93.50 during the latest trading session. Over the past one year, Morepen Laboratories Ltd has delivered a return of 102.94%, while the stock has declined 30.84% in the last one month.

    Morepen Laboratories Ltd performance

    Today’s low Today’s high
    ₹ 93.50 ₹ 99.15
    ₹ 96.80
    52 week low 52 week high
    ₹ 33.05 ₹ 150.70
    ₹ 96.80
    Open Price ₹ 93.50
    Prev. Close ₹ 94.43
    Volume (Shares) 6245943.00
    Total traded value ₹ 6046.07
    Upper Circuit ₹ 99.15
    Lower Circuit ₹ 89.71
    info

    Investment Returns

    Over 1 Month -30.84% Over 3 Months 19.29% Over 6 Months 106.90% Over 1 Year 102.94%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now


    • Market cap (Cr) 5,304.20
    • P/E Ratio (TTM) 29.48
    • Beta 1.04
    • Book Value / share 24.89
    • Return on equity 5.45%
    • EPS (TTM) 3.20
    • Dividend yield 0.21%
    • Net profit/quarter (Cr) 77.87
    info icon alternate text
    • Market cap (Cr) 5,359.00
    • P/E Ratio (TTM) 29.48
    • Beta 1.00
    • Book Value / share 24.89
    • Return on equity 5.45%
    • EPS (TTM) 3.20
    • Dividend yield 0.21%
    • Net profit/quarter (Cr) 77.87
    info icon alternate text

    Morepen Laboratories Ltd Financials

    Open financial information
    Revenue
    Net income
    Particulars SEP 2026 (Values in Cr)
    Revenue 678.00
    Operating Expense 582.78
    Net Profit 77.87
    Net Profit Margin (%) 11.48
    Earnings Per Share (EPS) 1.42
    EBITDA 118.45
    Effective Tax Rate (%) 24.87
    Particulars JUN 2026 (Values in Cr)
    Revenue 541.04
    Operating Expense 474.20
    Net Profit 54.00
    Net Profit Margin (%) 9.98
    Earnings Per Share (EPS) 0.99
    EBITDA 84.91
    Effective Tax Rate (%) 25.15
    Particulars MAR 2026 (Values in Cr)
    Revenue 462.81
    Operating Expense 444.00
    Net Profit 20.12
    Net Profit Margin (%) 4.34
    Earnings Per Share (EPS) 0.37
    EBITDA 32.13
    Effective Tax Rate (%) 27.14
    Particulars DEC 2025 (Values in Cr)
    Revenue 457.57
    Operating Expense 430.09
    Net Profit 23.50
    Net Profit Margin (%) 5.13
    Earnings Per Share (EPS) 0.43
    EBITDA 45.82
    Effective Tax Rate (%) 25.23
    Particulars SEP 2025 (Values in Cr)
    Revenue 369.53
    Operating Expense 356.42
    Net Profit 14.38
    Net Profit Margin (%) 3.89
    Earnings Per Share (EPS) 0.26
    EBITDA 33.67
    Effective Tax Rate (%) 23.80
    Particulars MAR 2026 (Values in Cr)
    Revenue 1681.20
    Operating Expense 1614.52
    Net Profit 66.06
    Net Profit Margin (%) 3.92
    Earnings Per Share (EPS) 1.21
    EBITDA 134.67
    Effective Tax Rate (%) 26.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 1554.54
    Operating Expense 1432.66
    Net Profit 101.58
    Net Profit Margin (%) 6.53
    Earnings Per Share (EPS) 1.90
    EBITDA 169.13
    Effective Tax Rate (%) 26.17
    Particulars MAR 2024 (Values in Cr)
    Revenue 1537.59
    Operating Expense 1401.18
    Net Profit 110.94
    Net Profit Margin (%) 7.21
    Earnings Per Share (EPS) 2.17
    EBITDA 174.39
    Effective Tax Rate (%) 25.53
    Particulars MAR 2023 (Values in Cr)
    Revenue 1338.88
    Operating Expense 1281.60
    Net Profit 46.24
    Net Profit Margin (%) 3.45
    Earnings Per Share (EPS) 0.92
    EBITDA 83.03
    Effective Tax Rate (%) 26.64
    Particulars MAR 2022 (Values in Cr)
    Revenue 1449.27
    Operating Expense 1333.95
    Net Profit 101.06
    Net Profit Margin (%) 6.97
    Earnings Per Share (EPS) 2.25
    EBITDA 139.36
    Effective Tax Rate (%) 19.49
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 22.75
    ROE % 5.37
    ROCE % 7.88
    Total Debt to Total Equity 0.13
    EBITDA Margin 8.14
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 21.10
    ROE % 11.78
    ROCE % 14.72
    Total Debt to Total Equity 0.07
    EBITDA Margin 10.62
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 16.58
    ROE % 12.08
    ROCE % 16.12
    Total Debt to Total Equity 0.03
    EBITDA Margin 10.21
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 14.73
    ROE % 5.81
    ROCE % 8.02
    Total Debt to Total Equity 0.03
    EBITDA Margin 6.04
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 11.56
    ROE % 20.27
    ROCE % 21.70
    Total Debt to Total Equity 0.04
    EBITDA Margin 9.50
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 22.68
    ROE % 5.45
    ROCE % 7.20
    Total Debt to Total Equity 0.12
    EBITDA Margin 8.01
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 21.56
    ROE % 9.81
    ROCE % 12.79
    Total Debt to Total Equity 0.06
    EBITDA Margin 10.88
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 17.39
    ROE % 13.29
    ROCE % 17.08
    Total Debt to Total Equity 0.03
    EBITDA Margin 11.34
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 15.26
    ROE % 6.71
    ROCE % 8.78
    Total Debt to Total Equity 0.03
    EBITDA Margin 6.20
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 11.97
    ROE % 19.38
    ROCE % 20.85
    Total Debt to Total Equity 0.03
    EBITDA Margin 9.62
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 68.82
    Total Assets 1936.12
    Total Liabilities 1936.12
    Total Equity 1247.08
    Share Outstanding 54
    Price to Book Ratio 1.49
    Return on Assets (%) 4.90
    Return on Capital (%) 6.58
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 49.36
    Total Assets 1778.09
    Total Liabilities 1778.09
    Total Equity 1186.95
    Share Outstanding 54
    Price to Book Ratio 2.22
    Return on Assets (%) 6.63
    Return on Capital (%) 9.32
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 52.11
    Total Assets 1293.20
    Total Liabilities 1293.20
    Total Equity 847.22
    Share Outstanding 51
    Price to Book Ratio 2.42
    Return on Assets (%) 7.43
    Return on Capital (%) 10.97
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 56.30
    Total Assets 1110.49
    Total Liabilities 1110.49
    Total Equity 752.44
    Share Outstanding 51
    Price to Book Ratio 1.68
    Return on Assets (%) 3.48
    Return on Capital (%) 4.97
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 45.97
    Total Assets 1070.05
    Total Liabilities 1070.05
    Total Equity 578.10
    Share Outstanding 47
    Price to Book Ratio 3.06
    Return on Assets (%) 9.50
    Return on Capital (%) 17.04
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 46.96
    Total Assets 1907.65
    Total Liabilities 1907.65
    Total Equity 1242.75
    Share Outstanding 54
    Price to Book Ratio 1.49
    Return on Assets (%) 3.46
    Return on Capital (%) 4.6
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 46.33
    Total Assets 1721.20
    Total Liabilities 1721.20
    Total Equity 1181.50
    Share Outstanding 54
    Price to Book Ratio 2.22
    Return on Assets (%) 5.90
    Return on Capital (%) 8.06
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 50.47
    Total Assets 1279.30
    Total Liabilities 1279.30
    Total Equity 889.02
    Share Outstanding 51
    Price to Book Ratio 2.42
    Return on Assets (%) 8.67
    Return on Capital (%) 12.09
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 55.90
    Total Assets 1105.54
    Total Liabilities 1105.54
    Total Equity 780.11
    Share Outstanding 51
    Price to Book Ratio 1.68
    Return on Assets (%) 4.18
    Return on Capital (%) 5.74
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 45.54
    Total Assets 1033.26
    Total Liabilities 1033.26
    Total Equity 598.16
    Share Outstanding 47
    Price to Book Ratio 3.06
    Return on Assets (%) 9.78
    Return on Capital (%) 16.39
    Particulars MAR 2026 (Values in Cr)
    Net Income 119.92
    Cash from Operations 57.92
    Cash from Investing -123.41
    Cash from Financing 97.39
    Net change in Cash 6.62
    Free Cash Flow 143.44
    Particulars MAR 2025 (Values in Cr)
    Net Income 155.10
    Cash from Operations 69.20
    Cash from Investing -321.50
    Cash from Financing 299.88
    Net change in Cash 10.43
    Free Cash Flow 193.24
    Particulars MAR 2024 (Values in Cr)
    Net Income 135.41
    Cash from Operations 111.48
    Cash from Investing -83.30
    Cash from Financing 5.20
    Net change in Cash -4.72
    Free Cash Flow 182.87
    Particulars MAR 2023 (Values in Cr)
    Net Income 55.75
    Cash from Operations -74.61
    Cash from Investing -46.50
    Cash from Financing 143.54
    Net change in Cash 5.86
    Free Cash Flow -38.99
    Particulars MAR 2022 (Values in Cr)
    Net Income 126.70
    Cash from Operations -35.30
    Cash from Investing -31.67
    Cash from Financing 66.33
    Net change in Cash -25.58
    Free Cash Flow 10.13
    Particulars MAR 2026 (Values in Cr)
    Net Income 89.26
    Cash from Operations 44.68
    Cash from Investing -119.02
    Cash from Financing 97.12
    Net change in Cash -1.42
    Free Cash Flow 128.44
    Particulars MAR 2025 (Values in Cr)
    Net Income 137.58
    Cash from Operations 65.14
    Cash from Investing -280.42
    Cash from Financing 260.46
    Net change in Cash 9.12
    Free Cash Flow 189.10
    Particulars MAR 2024 (Values in Cr)
    Net Income 148.97
    Cash from Operations 114.72
    Cash from Investing -83.60
    Cash from Financing 0.28
    Net change in Cash -5.95
    Free Cash Flow 185.95
    Particulars MAR 2023 (Values in Cr)
    Net Income 63.04
    Cash from Operations -85.84
    Cash from Investing -36.19
    Cash from Financing 144.19
    Net change in Cash 5.88
    Free Cash Flow -50.29
    Particulars MAR 2022 (Values in Cr)
    Net Income 125.54
    Cash from Operations -44.47
    Cash from Investing -22.64
    Cash from Financing 66.41
    Net change in Cash -25.09
    Free Cash Flow 0.68
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 35.51 17.58 1.66 272.12 23.12 49.98
    BLISS GVS PHARMA LTD. 620.10 40.56 5.11 6596.87 118.35 744.75
    CIPLA LTD 1410.95 36.71 3.22 113988.97 1165.55 1539.25
    FERMENTA BIOTECH LIMITED 454.65 28.81 3.19 1338.08 256.40 582.95
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 35.51 60.19 4.57 272.12 23.12 49.98
    AMRUTANJAN HEALTH CARE LTD. 518.10 22.85 3.90 1497.86 476.85 744.00
    ASTRAZENECA PHARMA INDIA LTD. 6480.05 86.07 18.43 16200.13 5660.00 9449.00
    BLISS GVS PHARMA LTD. 620.10 49.25 5.21 6596.87 118.35 744.75

    Morepen Laboratories Ltd shareholding pattern

    Holding
    59.2%
    35.65%
    3.43%
    1.7%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Morepen Laboratories Ltd Technicals Summary

    96.80 2.50 redarrow
    red-green-graph indicator
    12 Bearish
    4 Bullish
    • 5 Days 100.50
    • 26 Days 114.90
    • 10 Days 107.40
    • 50 Days 111.30
    • 12 Days 109.30
    • 100 Days 96.80
    • 20 Days 113.80
    • 200 Days 79.40
    92.60 PIVOT
    First Support 90.19 First Resistance 96.83 Second Support 85.96 Second Resistance 99.24 Third Support 83.55 Third Resistance 103.47
    RSI 33.16 ADX 19.72 MACD -5.65 Williams % R -86.19 Commodity Channel Index (CCI) -157.77
    Date 2026-10-12 Week 6058004.00 Same Day 5054104.00 Month 5527101.00
    1 Year 1.05 3 Year 1.39
    Over 1 Month
    -30.84% down
    Over 1 Year
    102.94% down
    Over 3 Months
    19.29% down
    Over 3 Years
    37.84% down
    Over 6 Months
    106.90% down
    Over 5 Years
    13.15% down

    Morepen Laboratories Ltd Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Nov 2026 0.02 Interim 23 Nov 2026 Equity shares
    20 Nov 2026 0.5 Interim 20 Nov 2026 Equity shares
    19 Nov 2026 20.0 Interim 19 Nov 2026 Equity shares
    17 Nov 2026 4.1 Interim 2 17 Nov 2026 Equity shares
    16 Nov 2026 0.9 Interim 16 Nov 2026 Equity shares
    16 Nov 2026 4.0 Interim 16 Nov 2026 Equity shares
    13 Nov 2026 14.4 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 1.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 6.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 0.5 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 10.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.35 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.05 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 11.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.75 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 10.0 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 1 13 Nov 2026 Equity shares
    13 Nov 2026 1.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 1.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 1.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 1.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 3.25 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 0.1 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 1 13 Nov 2026 Equity shares
    13 Nov 2026 0.01 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    12 Nov 2026 90.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 19.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 10.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 2.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 40.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 1.5 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 5.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 8.0 Interim 1 12 Nov 2026 Equity shares
    12 Nov 2026 3.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 5.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 0.05 Interim 2 12 Nov 2026 Equity shares
    12 Nov 2026 1.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 0.5 Interim 1 12 Nov 2026 Equity shares
    11 Nov 2026 4.0 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 1.5 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 1.5 Special 11 Nov 2026 Equity shares
    11 Nov 2026 1.65 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 4.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 0.6 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 5.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 7.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 2.5 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 6.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 18.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 1.35 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 1.25 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 1.9 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 0.25 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 0.19 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 1.0 Interim 1 11 Nov 2026 Equity shares
    11 Nov 2026 5.0 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 2.2 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 4.12 Final 11 Nov 2026 Equity shares
    11 Nov 2026 0.5 Interim 11 Nov 2026 Equity shares
    09 Nov 2026 0.5 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 20.0 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 3.5 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 0.5 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 3.7 Interim 09 Nov 2026 Equity shares
    09 Nov 2026 1.0 Interim 09 Nov 2026 Equity shares
    09 Nov 2026 2.05 Final 10 Nov 2026 Equity shares
    09 Nov 2026 1.0 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 2.0 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 7.8073 Final 10 Nov 2026 Equity shares
    09 Nov 2026 1.67 Final 09 Nov 2026 Equity shares
    09 Nov 2026 2.43 Final 09 Nov 2026 Equity shares
    06 Nov 2026 1.0 Interim 1 07 Nov 2026 Equity shares
    06 Nov 2026 2.15 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 4.05 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 4.3 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 4.5 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 3.0 Interim 1 06 Nov 2026 Equity shares
    06 Nov 2026 0.15 Interim 2 06 Nov 2026 Equity shares
    06 Nov 2026 3.0 Interim 1 06 Nov 2026 Equity shares
    06 Nov 2026 10.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 2.2 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 3.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 7.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 2.0 Interim 1 06 Nov 2026 Equity shares
    06 Nov 2026 2.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 2.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 5.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 5.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 0.25 Interim 2 06 Nov 2026 Equity shares
    06 Nov 2026 1.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 3.05 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 0.05 Interim 06 Nov 2026 Equity shares
    Ex-Date Ex-Bonus Ratio
    13 Nov 2026 13 Nov 2026 1:1
    04 Nov 2026 04 Nov 2026 1:1
    02 Nov 2026 02 Nov 2026 2:5
    23 Oct 2026 23 Oct 2026 1:4
    15 Oct 2026 15 Oct 2026 1:2
    12 Oct 2026 12 Oct 2026 1:1
    09 Oct 2026 09 Oct 2026 1:1
    09 Oct 2026 09 Oct 2026 1:1
    09 Oct 2026 09 Oct 2026 1:1
    07 Oct 2026 07 Oct 2026 10:1
    07 Oct 2026 07 Oct 2026 2:1
    01 Oct 2026 01 Oct 2026 1:1
    01 Oct 2026 01 Oct 2026 1:1
    28 Sep 2026 28 Sep 2026 1:1
    24 Sep 2026 24 Sep 2026 1:1
    12 Sep 2026 11 Sep 2026 1:1
    11 Sep 2026 11 Sep 2026 1:1
    04 Sep 2026 04 Sep 2026 7:24
    24 Aug 2026 24 Aug 2026 1:1
    24 Aug 2026 24 Aug 2026 1:1
    21 Aug 2026 21 Aug 2026 2:1
    20 Aug 2026 20 Aug 2026 1:2
    20 Aug 2026 20 Aug 2026 3:1
    17 Aug 2026 17 Aug 2026 5:1
    31 Jul 2026 31 Jul 2026 1:5
    28 Jul 2026 28 Jul 2026 2:5
    24 Jul 2026 24 Jul 2026 1:2
    16 Jul 2026 16 Jul 2026 2:1
    10 Jul 2026 10 Jul 2026 2:1
    10 Jul 2026 10 Jul 2026 1:3
    07 Jul 2026 07 Jul 2026 5:1
    02 Jul 2026 02 Jul 2026 2:1
    24 Jun 2026 24 Jun 2026 10:1
    24 Jun 2026 24 Jun 2026 5:1
    19 Jun 2026 19 Jun 2026 2:9
    17 Jun 2026 17 Jun 2026 1:3
    16 Jun 2026 16 Jun 2026 1:1
    12 Jun 2026 12 Jun 2026 1:3
    10 Jun 2026 10 Jun 2026 3:1
    04 Jun 2026 04 Jun 2026 1:2
    03 Jun 2026 03 Jun 2026 1:1
    29 May 2026 29 May 2026 1:1
    26 May 2026 26 May 2026 1:10
    25 May 2026 25 May 2026 6:1
    15 May 2026 15 May 2026 1:6
    15 May 2026 15 May 2026 1:1
    12 May 2026 12 May 2026 3:2
    08 May 2026 08 May 2026 6:1
    24 Apr 2026 24 Apr 2026 4:1
    24 Apr 2026 24 Apr 2026 1:1
    10 Apr 2026 10 Apr 2026 5:7
    07 Apr 2026 07 Apr 2026 3:1
    03 Apr 2026 02 Apr 2026 1:2
    02 Apr 2026 02 Apr 2026 1:2
    01 Apr 2026 30 Mar 2026 1:1
    01 Apr 2026 30 Mar 2026 3:1
    27 Mar 2026 27 Mar 2026 1:1
    24 Mar 2026 24 Mar 2026 1:1
    24 Mar 2026 24 Mar 2026 1:1
    20 Mar 2026 20 Mar 2026 3:1
    13 Mar 2026 13 Mar 2026 1:1
    13 Mar 2026 13 Mar 2026 2:1
    10 Mar 2026 10 Mar 2026 1:10
    09 Mar 2026 09 Mar 2026 4:1
    06 Mar 2026 06 Mar 2026 4:1
    06 Mar 2026 06 Mar 2026 1:2
    06 Mar 2026 06 Mar 2026 1:1
    06 Mar 2026 06 Mar 2026 1:10
    02 Mar 2026 02 Mar 2026 7:5
    27 Feb 2026 27 Feb 2026 3:1
    19 Feb 2026 18 Feb 2026 1:1
    17 Feb 2026 17 Feb 2026 1:2
    13 Feb 2026 13 Feb 2026 1:10
    14 Feb 2026 13 Feb 2026 2:1
    23 Jan 2026 23 Jan 2026 5:40
    16 Jan 2026 16 Jan 2026 1:2
    13 Jan 2026 13 Jan 2026 4:1
    09 Jan 2026 09 Jan 2026 1:10
    05 Jan 2026 05 Jan 2026 1:10
    02 Jan 2026 02 Jan 2026 4:1
    02 Jan 2026 02 Jan 2026 23:1
    02 Jan 2026 02 Jan 2026 1:1
    31 Dec 2025 31 Dec 2025 3:1
    26 Dec 2025 26 Dec 2025 1:1
    24 Dec 2025 24 Dec 2025 2:1
    19 Dec 2025 19 Dec 2025 1:1
    19 Dec 2025 19 Dec 2025 4:1
    18 Dec 2025 18 Dec 2025 3:1
    17 Dec 2025 17 Dec 2025 5:11
    15 Dec 2025 15 Dec 2025 1:1
    12 Dec 2025 12 Dec 2025 1:1
    08 Dec 2025 08 Dec 2025 1:1
    05 Dec 2025 05 Dec 2025 5:2
    05 Dec 2025 05 Dec 2025 24:1
    05 Dec 2025 05 Dec 2025 1:1
    28 Nov 2025 28 Nov 2025 2:1
    26 Nov 2025 26 Nov 2025 1:1
    21 Nov 2025 21 Nov 2025 2:10
    19 Nov 2025 19 Nov 2025 3:5
    18 Nov 2025 18 Nov 2025 5:1
    Ex-Date Old FV NEW FV Record Date
    30 Nov 2026 10.0 2.0 30 Nov 2026
    16 Nov 2026 10.0 1.0 16 Nov 2026
    06 Nov 2026 5.0 1.0 06 Nov 2026
    06 Nov 2026 2.0 10.0 06 Nov 2026
    05 Nov 2026 10.0 1.0 05 Nov 2026
    30 Oct 2026 10.0 5.0 30 Oct 2026
    30 Oct 2026 10.0 1.0 30 Oct 2026
    29 Oct 2026 10.0 1.0 29 Oct 2026
    26 Oct 2026 10.0 5.0 26 Oct 2026
    23 Oct 2026 10.0 2.0 23 Oct 2026
    22 Oct 2026 10.0 1.0 22 Oct 2026
    19 Oct 2026 10.0 1.0 19 Oct 2026
    16 Oct 2026 5.0 1.0 16 Oct 2026
    16 Oct 2026 5.0 10.0 16 Oct 2026
    15 Oct 2026 10.0 2.0 15 Oct 2026
    13 Oct 2026 1.0 10.0 13 Oct 2026
    08 Oct 2026 10.0 2.0 08 Oct 2026
    06 Oct 2026 10.0 5.0 06 Oct 2026
    25 Sep 2026 10.0 5.0 25 Sep 2026
    25 Sep 2026 10.0 1.0 25 Sep 2026
    22 Sep 2026 10.0 2.0 22 Sep 2026
    18 Sep 2026 10.0 2.0 18 Sep 2026
    18 Sep 2026 10.0 1.0 18 Sep 2026
    04 Sep 2026 10.0 2.0 04 Sep 2026
    04 Sep 2026 10.0 1.0 04 Sep 2026
    28 Aug 2026 10.0 1.0 28 Aug 2026
    28 Aug 2026 10.0 1.0 28 Aug 2026
    28 Aug 2026 10.0 2.0 28 Aug 2026
    28 Aug 2026 10.0 2.0 28 Aug 2026
    25 Aug 2026 10.0 1.0 26 Aug 2026
    24 Aug 2026 2.0 1.0 24 Aug 2026
    18 Aug 2026 2.0 1.0 18 Aug 2026
    07 Aug 2026 10.0 5.0 07 Aug 2026
    05 Aug 2026 10.0 1.0 05 Aug 2026
    31 Jul 2026 10.0 5.0 31 Jul 2026
    31 Jul 2026 10.0 1.0 31 Jul 2026
    24 Jul 2026 10.0 2.0 24 Jul 2026
    24 Jul 2026 10.0 2.0 24 Jul 2026
    24 Jul 2026 10.0 2.0 24 Jul 2026
    21 Jul 2026 5.0 2.0 21 Jul 2026
    20 Jul 2026 10.0 2.0 20 Jul 2026
    17 Jul 2026 10.0 2.0 17 Jul 2026
    10 Jul 2026 10.0 1.0 10 Jul 2026
    10 Jul 2026 10.0 1.0 10 Jul 2026
    08 Jul 2026 10.0 1.0 08 Jul 2026
    03 Jul 2026 10.0 1.0 03 Jul 2026
    03 Jul 2026 10.0 1.0 03 Jul 2026
    03 Jul 2026 10.0 2.0 03 Jul 2026
    03 Jul 2026 10.0 2.0 03 Jul 2026
    19 Jun 2026 10.0 1.0 19 Jun 2026
    12 Jun 2026 10.0 2.0 12 Jun 2026
    05 Jun 2026 10.0 1.0 05 Jun 2026
    29 May 2026 10.0 2.0 29 May 2026
    26 May 2026 10.0 2.0 26 May 2026
    26 May 2026 10.0 1.0 26 May 2026
    22 May 2026 10.0 5.0 22 May 2026
    15 May 2026 10.0 5.0 15 May 2026
    05 May 2026 10.0 1.0 05 May 2026
    30 Apr 2026 100.0 1.0 30 Apr 2026
    30 Apr 2026 1.0 10.0 30 Apr 2026
    24 Apr 2026 10.0 2.0 24 Apr 2026
    24 Apr 2026 10.0 1.0 24 Apr 2026
    17 Apr 2026 10.0 1.0 17 Apr 2026
    02 Apr 2026 2.0 1.0 03 Apr 2026
    27 Mar 2026 10.0 5.0 27 Mar 2026
    25 Mar 2026 10.0 1.0 26 Mar 2026
    25 Mar 2026 10.0 1.0 25 Mar 2026
    13 Mar 2026 10.0 2.0 13 Mar 2026
    09 Mar 2026 10.0 5.0 09 Mar 2026
    06 Mar 2026 10.0 2.0 06 Mar 2026
    06 Mar 2026 10.0 5.0 06 Mar 2026
    06 Mar 2026 100.0 1.0 06 Mar 2026
    05 Mar 2026 10.0 1.0 05 Mar 2026
    02 Mar 2026 10.0 5.0 02 Mar 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    26 Feb 2026 10.0 1.0 26 Feb 2026
    25 Feb 2026 10.0 1.0 25 Feb 2026
    20 Feb 2026 10.0 2.0 20 Feb 2026
    13 Feb 2026 10.0 2.0 14 Feb 2026
    13 Feb 2026 10.0 1.0 13 Feb 2026
    06 Feb 2026 10.0 1.0 06 Feb 2026
    06 Feb 2026 10.0 1.0 06 Feb 2026
    06 Feb 2026 10.0 2.0 06 Feb 2026
    06 Feb 2026 10.0 1.0 06 Feb 2026
    22 Jan 2026 5.0 1.0 22 Jan 2026
    16 Jan 2026 10.0 1.0 16 Jan 2026
    14 Jan 2026 10.0 2.0 15 Jan 2026
    14 Jan 2026 5.0 1.0 14 Jan 2026
    12 Jan 2026 10.0 5.0 12 Jan 2026
    08 Jan 2026 10.0 1.0 08 Jan 2026
    02 Jan 2026 10.0 2.0 02 Jan 2026
    29 Dec 2025 1.0 10.0 29 Dec 2025
    26 Dec 2025 10.0 2.0 26 Dec 2025
    22 Dec 2025 10.0 5.0 22 Dec 2025
    19 Dec 2025 10.0 1.0 19 Dec 2025
    12 Dec 2025 10.0 2.0 12 Dec 2025
    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Nov 2026 0.02 Interim 23 Nov 2026 Equity shares
    20 Nov 2026 0.5 Interim 20 Nov 2026 Equity shares
    19 Nov 2026 20.0 Interim 19 Nov 2026 Equity shares
    17 Nov 2026 4.1 Interim 2 17 Nov 2026 Equity shares
    16 Nov 2026 0.9 Interim 16 Nov 2026 Equity shares
    16 Nov 2026 4.0 Interim 16 Nov 2026 Equity shares
    13 Nov 2026 14.4 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 1.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 6.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 0.5 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 10.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.35 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.05 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 11.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.75 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 10.0 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 1 13 Nov 2026 Equity shares
    13 Nov 2026 1.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 1.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 1.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 1.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 3.25 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 0.1 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 1 13 Nov 2026 Equity shares
    13 Nov 2026 0.01 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    12 Nov 2026 90.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 19.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 10.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 2.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 40.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 1.5 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 5.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 8.0 Interim 1 12 Nov 2026 Equity shares
    12 Nov 2026 3.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 5.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 0.05 Interim 2 12 Nov 2026 Equity shares
    12 Nov 2026 1.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 0.5 Interim 1 12 Nov 2026 Equity shares
    11 Nov 2026 4.0 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 1.5 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 1.5 Special 11 Nov 2026 Equity shares
    11 Nov 2026 1.65 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 4.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 0.6 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 5.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 7.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 2.5 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 6.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 18.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 1.35 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 1.25 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 1.9 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 0.25 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 0.19 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 1.0 Interim 1 11 Nov 2026 Equity shares
    11 Nov 2026 5.0 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 2.2 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 4.12 Final 11 Nov 2026 Equity shares
    11 Nov 2026 0.5 Interim 11 Nov 2026 Equity shares
    09 Nov 2026 0.5 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 20.0 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 3.5 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 0.5 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 3.7 Interim 09 Nov 2026 Equity shares
    09 Nov 2026 1.0 Interim 09 Nov 2026 Equity shares
    09 Nov 2026 2.05 Final 10 Nov 2026 Equity shares
    09 Nov 2026 1.0 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 2.0 Interim 10 Nov 2026 Equity shares
    09 Nov 2026 7.8073 Final 10 Nov 2026 Equity shares
    09 Nov 2026 1.67 Final 09 Nov 2026 Equity shares
    09 Nov 2026 2.43 Final 09 Nov 2026 Equity shares
    06 Nov 2026 1.0 Interim 1 07 Nov 2026 Equity shares
    06 Nov 2026 2.15 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 4.05 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 4.3 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 4.5 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 3.0 Interim 1 06 Nov 2026 Equity shares
    06 Nov 2026 0.15 Interim 2 06 Nov 2026 Equity shares
    06 Nov 2026 3.0 Interim 1 06 Nov 2026 Equity shares
    06 Nov 2026 10.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 2.2 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 3.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 7.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 2.0 Interim 1 06 Nov 2026 Equity shares
    06 Nov 2026 2.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 2.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 5.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 5.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 0.25 Interim 2 06 Nov 2026 Equity shares
    06 Nov 2026 1.0 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 3.05 Interim 06 Nov 2026 Equity shares
    06 Nov 2026 0.05 Interim 06 Nov 2026 Equity shares
    Ex-Date Ex-Bonus Ratio
    13 Nov 2026 13 Nov 2026 1:1
    04 Nov 2026 04 Nov 2026 1:1
    02 Nov 2026 02 Nov 2026 2:5
    23 Oct 2026 23 Oct 2026 1:4
    15 Oct 2026 15 Oct 2026 1:2
    12 Oct 2026 12 Oct 2026 1:1
    09 Oct 2026 09 Oct 2026 1:1
    09 Oct 2026 09 Oct 2026 1:1
    09 Oct 2026 09 Oct 2026 1:1
    07 Oct 2026 07 Oct 2026 10:1
    07 Oct 2026 07 Oct 2026 2:1
    01 Oct 2026 01 Oct 2026 1:1
    01 Oct 2026 01 Oct 2026 1:1
    28 Sep 2026 28 Sep 2026 1:1
    24 Sep 2026 24 Sep 2026 1:1
    12 Sep 2026 11 Sep 2026 1:1
    11 Sep 2026 11 Sep 2026 1:1
    04 Sep 2026 04 Sep 2026 7:24
    24 Aug 2026 24 Aug 2026 1:1
    24 Aug 2026 24 Aug 2026 1:1
    21 Aug 2026 21 Aug 2026 2:1
    20 Aug 2026 20 Aug 2026 1:2
    20 Aug 2026 20 Aug 2026 3:1
    17 Aug 2026 17 Aug 2026 5:1
    31 Jul 2026 31 Jul 2026 1:5
    28 Jul 2026 28 Jul 2026 2:5
    24 Jul 2026 24 Jul 2026 1:2
    16 Jul 2026 16 Jul 2026 2:1
    10 Jul 2026 10 Jul 2026 2:1
    10 Jul 2026 10 Jul 2026 1:3
    07 Jul 2026 07 Jul 2026 5:1
    02 Jul 2026 02 Jul 2026 2:1
    24 Jun 2026 24 Jun 2026 10:1
    24 Jun 2026 24 Jun 2026 5:1
    19 Jun 2026 19 Jun 2026 2:9
    17 Jun 2026 17 Jun 2026 1:3
    16 Jun 2026 16 Jun 2026 1:1
    12 Jun 2026 12 Jun 2026 1:3
    10 Jun 2026 10 Jun 2026 3:1
    04 Jun 2026 04 Jun 2026 1:2
    03 Jun 2026 03 Jun 2026 1:1
    29 May 2026 29 May 2026 1:1
    26 May 2026 26 May 2026 1:10
    25 May 2026 25 May 2026 6:1
    15 May 2026 15 May 2026 1:6
    15 May 2026 15 May 2026 1:1
    12 May 2026 12 May 2026 3:2
    08 May 2026 08 May 2026 6:1
    24 Apr 2026 24 Apr 2026 4:1
    24 Apr 2026 24 Apr 2026 1:1
    10 Apr 2026 10 Apr 2026 5:7
    07 Apr 2026 07 Apr 2026 3:1
    03 Apr 2026 02 Apr 2026 1:2
    02 Apr 2026 02 Apr 2026 1:2
    01 Apr 2026 30 Mar 2026 1:1
    01 Apr 2026 30 Mar 2026 3:1
    27 Mar 2026 27 Mar 2026 1:1
    24 Mar 2026 24 Mar 2026 1:1
    24 Mar 2026 24 Mar 2026 1:1
    20 Mar 2026 20 Mar 2026 3:1
    13 Mar 2026 13 Mar 2026 1:1
    13 Mar 2026 13 Mar 2026 2:1
    10 Mar 2026 10 Mar 2026 1:10
    09 Mar 2026 09 Mar 2026 4:1
    06 Mar 2026 06 Mar 2026 4:1
    06 Mar 2026 06 Mar 2026 1:2
    06 Mar 2026 06 Mar 2026 1:1
    06 Mar 2026 06 Mar 2026 1:10
    02 Mar 2026 02 Mar 2026 7:5
    27 Feb 2026 27 Feb 2026 3:1
    19 Feb 2026 18 Feb 2026 1:1
    17 Feb 2026 17 Feb 2026 1:2
    13 Feb 2026 13 Feb 2026 1:10
    14 Feb 2026 13 Feb 2026 2:1
    23 Jan 2026 23 Jan 2026 5:40
    16 Jan 2026 16 Jan 2026 1:2
    13 Jan 2026 13 Jan 2026 4:1
    09 Jan 2026 09 Jan 2026 1:10
    05 Jan 2026 05 Jan 2026 1:10
    02 Jan 2026 02 Jan 2026 4:1
    02 Jan 2026 02 Jan 2026 23:1
    02 Jan 2026 02 Jan 2026 1:1
    31 Dec 2025 31 Dec 2025 3:1
    26 Dec 2025 26 Dec 2025 1:1
    24 Dec 2025 24 Dec 2025 2:1
    19 Dec 2025 19 Dec 2025 1:1
    19 Dec 2025 19 Dec 2025 4:1
    18 Dec 2025 18 Dec 2025 3:1
    17 Dec 2025 17 Dec 2025 5:11
    15 Dec 2025 15 Dec 2025 1:1
    12 Dec 2025 12 Dec 2025 1:1
    08 Dec 2025 08 Dec 2025 1:1
    05 Dec 2025 05 Dec 2025 5:2
    05 Dec 2025 05 Dec 2025 24:1
    05 Dec 2025 05 Dec 2025 1:1
    28 Nov 2025 28 Nov 2025 2:1
    26 Nov 2025 26 Nov 2025 1:1
    21 Nov 2025 21 Nov 2025 2:10
    19 Nov 2025 19 Nov 2025 3:5
    18 Nov 2025 18 Nov 2025 5:1
    Ex-Date Old FV NEW FV Record Date
    30 Nov 2026 10.0 2.0 30 Nov 2026
    16 Nov 2026 10.0 1.0 16 Nov 2026
    06 Nov 2026 5.0 1.0 06 Nov 2026
    06 Nov 2026 2.0 10.0 06 Nov 2026
    05 Nov 2026 10.0 1.0 05 Nov 2026
    30 Oct 2026 10.0 5.0 30 Oct 2026
    30 Oct 2026 10.0 1.0 30 Oct 2026
    29 Oct 2026 10.0 1.0 29 Oct 2026
    26 Oct 2026 10.0 5.0 26 Oct 2026
    23 Oct 2026 10.0 2.0 23 Oct 2026
    22 Oct 2026 10.0 1.0 22 Oct 2026
    19 Oct 2026 10.0 1.0 19 Oct 2026
    16 Oct 2026 5.0 1.0 16 Oct 2026
    16 Oct 2026 5.0 10.0 16 Oct 2026
    15 Oct 2026 10.0 2.0 15 Oct 2026
    13 Oct 2026 1.0 10.0 13 Oct 2026
    08 Oct 2026 10.0 2.0 08 Oct 2026
    06 Oct 2026 10.0 5.0 06 Oct 2026
    25 Sep 2026 10.0 5.0 25 Sep 2026
    25 Sep 2026 10.0 1.0 25 Sep 2026
    22 Sep 2026 10.0 2.0 22 Sep 2026
    18 Sep 2026 10.0 2.0 18 Sep 2026
    18 Sep 2026 10.0 1.0 18 Sep 2026
    04 Sep 2026 10.0 2.0 04 Sep 2026
    04 Sep 2026 10.0 1.0 04 Sep 2026
    28 Aug 2026 10.0 1.0 28 Aug 2026
    28 Aug 2026 10.0 1.0 28 Aug 2026
    28 Aug 2026 10.0 2.0 28 Aug 2026
    28 Aug 2026 10.0 2.0 28 Aug 2026
    25 Aug 2026 10.0 1.0 26 Aug 2026
    24 Aug 2026 2.0 1.0 24 Aug 2026
    18 Aug 2026 2.0 1.0 18 Aug 2026
    07 Aug 2026 10.0 5.0 07 Aug 2026
    05 Aug 2026 10.0 1.0 05 Aug 2026
    31 Jul 2026 10.0 5.0 31 Jul 2026
    31 Jul 2026 10.0 1.0 31 Jul 2026
    24 Jul 2026 10.0 2.0 24 Jul 2026
    24 Jul 2026 10.0 2.0 24 Jul 2026
    24 Jul 2026 10.0 2.0 24 Jul 2026
    21 Jul 2026 5.0 2.0 21 Jul 2026
    20 Jul 2026 10.0 2.0 20 Jul 2026
    17 Jul 2026 10.0 2.0 17 Jul 2026
    10 Jul 2026 10.0 1.0 10 Jul 2026
    10 Jul 2026 10.0 1.0 10 Jul 2026
    08 Jul 2026 10.0 1.0 08 Jul 2026
    03 Jul 2026 10.0 1.0 03 Jul 2026
    03 Jul 2026 10.0 1.0 03 Jul 2026
    03 Jul 2026 10.0 2.0 03 Jul 2026
    03 Jul 2026 10.0 2.0 03 Jul 2026
    19 Jun 2026 10.0 1.0 19 Jun 2026
    12 Jun 2026 10.0 2.0 12 Jun 2026
    05 Jun 2026 10.0 1.0 05 Jun 2026
    29 May 2026 10.0 2.0 29 May 2026
    26 May 2026 10.0 2.0 26 May 2026
    26 May 2026 10.0 1.0 26 May 2026
    22 May 2026 10.0 5.0 22 May 2026
    15 May 2026 10.0 5.0 15 May 2026
    05 May 2026 10.0 1.0 05 May 2026
    30 Apr 2026 100.0 1.0 30 Apr 2026
    30 Apr 2026 1.0 10.0 30 Apr 2026
    24 Apr 2026 10.0 2.0 24 Apr 2026
    24 Apr 2026 10.0 1.0 24 Apr 2026
    17 Apr 2026 10.0 1.0 17 Apr 2026
    02 Apr 2026 2.0 1.0 03 Apr 2026
    27 Mar 2026 10.0 5.0 27 Mar 2026
    25 Mar 2026 10.0 1.0 26 Mar 2026
    25 Mar 2026 10.0 1.0 25 Mar 2026
    13 Mar 2026 10.0 2.0 13 Mar 2026
    09 Mar 2026 10.0 5.0 09 Mar 2026
    06 Mar 2026 10.0 2.0 06 Mar 2026
    06 Mar 2026 10.0 5.0 06 Mar 2026
    06 Mar 2026 100.0 1.0 06 Mar 2026
    05 Mar 2026 10.0 1.0 05 Mar 2026
    02 Mar 2026 10.0 5.0 02 Mar 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    26 Feb 2026 10.0 1.0 26 Feb 2026
    25 Feb 2026 10.0 1.0 25 Feb 2026
    20 Feb 2026 10.0 2.0 20 Feb 2026
    13 Feb 2026 10.0 2.0 14 Feb 2026
    13 Feb 2026 10.0 1.0 13 Feb 2026
    06 Feb 2026 10.0 1.0 06 Feb 2026
    06 Feb 2026 10.0 1.0 06 Feb 2026
    06 Feb 2026 10.0 2.0 06 Feb 2026
    06 Feb 2026 10.0 1.0 06 Feb 2026
    22 Jan 2026 5.0 1.0 22 Jan 2026
    16 Jan 2026 10.0 1.0 16 Jan 2026
    14 Jan 2026 10.0 2.0 15 Jan 2026
    14 Jan 2026 5.0 1.0 14 Jan 2026
    12 Jan 2026 10.0 5.0 12 Jan 2026
    08 Jan 2026 10.0 1.0 08 Jan 2026
    02 Jan 2026 10.0 2.0 02 Jan 2026
    29 Dec 2025 1.0 10.0 29 Dec 2025
    26 Dec 2025 10.0 2.0 26 Dec 2025
    22 Dec 2025 10.0 5.0 22 Dec 2025
    19 Dec 2025 10.0 1.0 19 Dec 2025
    12 Dec 2025 10.0 2.0 12 Dec 2025

    Top Gainers

    Top Losers

    About the Company


    Morepen Laboratories Limited
    , established in 1984 and headquartered in New Delhi, is a leading Indian pharmaceutical and healthcare company with a strong global presence. Over four decades, the company has built expertise across active pharmaceutical ingredients (APIs), finished formulations, diagnostic devices, and over-the-counter healthcare products.

    Listed on the National Stock Exchange and the Bombay Stock Exchange, Morepen serves more than 100 million consumers across domestic and international markets through its diversified healthcare portfolio.

    The company's key therapeutic segments include respiratory care, anti-allergic treatments, cardiovascular medicines, antibiotics, and gastrointestinal solutions. Its well-known brands include Dr. Morepen, Montelast, and Saltum, which have established a strong presence in their respective categories.

    Driven by research, continuous innovation, and stringent quality standards, Morepen Laboratories remains committed to advancing healthcare delivery and improving health and wellness outcomes for consumers worldwide.

    Morepen Laboratories Result Highlights

    Revenue: Consolidated revenue from operations was ₹746.50 Cr in Q2 FY 2026-27, up 30.9% QoQ (from ₹570.13 Cr) and up 81.4% YoY (from ₹411.58 Cr).

    Expenses: Total expenses (before exceptional items) were ₹638.65 Cr, up 27.5% QoQ and up 61.1% YoY.

    Net Profit: Consolidated net profit (PAT) was ₹88.89 Cr, up 57.7% QoQ (from ₹56.35 Cr) and up 116.6% YoY (from ₹41.04 Cr). Profit attributable to owners was ₹88.89 Cr (₹56.40 Cr in Q1 FY 2026-27 and ₹40.87 Cr a year ago). Q2 FY26 profit included an exceptional gain of about ₹25.83 Cr.

    EPS: Basic EPS was ₹1.62 for Q2 FY 2026-27 (₹1.03 in Q1 FY 2026-27 and ₹0.75 a year ago).

    Data Source: BSE, NSE, Company announcements

    The financial results presented are for informational purposes only and should not be construed as investment advice or recommendations.

     

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Morepen Laboratories Ltd?

    Morepen Laboratories Ltd share price is for NSE ₹ 98.37 & for BSE ₹ 98.00 as on Nov 09 2026 01:43 PM.

    What is the Market Cap of Morepen Laboratories Ltd Share?

    The market cap of Morepen Laboratories Ltd for NSE ₹ 5,174.33 & for BSE ₹ 5,169.94 as on Nov 09 2026 01:43 PM.

    What is the 52 Week High and Low of Morepen Laboratories Ltd?

    The 52 Week High and Low of Morepen Laboratories Ltd for NSE is ₹ 150.70 and ₹ 33.05 and for BSE is ₹ 150.80 and ₹ 33.44.

    What is 1 year return for Morepen Laboratories Ltd?

    The 1 year returns on the stock has been 102.94%.

    What is the P/E Ratio of Morepen Laboratories Ltd Share?

    As on Nov 09 2026 01:43 PM the price-to-earnings (PE) ratio for Morepen Laboratories Ltd share is 29.48.

    What is the PB ratio of Morepen Laboratories Ltd Share?

    As on Nov 09 2026 01:43 PM, the price-to-book (PB) ratio for Morepen Laboratories Ltd share is 24.89.

    How to Buy Morepen Laboratories Ltd Share?

    You can trade in Morepen Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Morepen Laboratories Ltd Share on Bajaj Broking App?

    To buy Morepen Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Morepen Laboratories Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    Bajaj Broking Regulatory Details

    SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | MCX Member ID: 57680 | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403 | APMI APRN : APRN04289.

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |